Wells Fargo
KZIA

Wells Fargo’s Kazia Therapeutics KZIA Stock Holding History

Wells Fargo’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$3 – 7269
2025
Q1 		$3 Buy
+1
New +$6 ﹤0.01% 6926
2024
Q4 		– Sell
-10
Closed -$231 – 6932
2024
Q3 		$215 Hold
10
– – ﹤0.01% 6224
2024
Q2 		$114 Hold
10
– – ﹤0.01% 6240
2024
Q1 		$155 Buy
+10
New +$150 ﹤0.01% 6561
2023
Q1 		– Sell
-4
Closed -$123 – 7748
2022
Q4 		$123 Hold
4
– – ﹤0.01% 6748
2022
Q3 		$0 Hold
4
– – ﹤0.01% 7037
2022
Q2 		$1K Sell
4
-6
-60% -$1.84K ﹤0.01% 6540
2022
Q1 		$4K Hold
10
– – ﹤0.01% 6528
2021
Q4 		$4K Hold
10
– – ﹤0.01% 6754
2021
Q3 		$6K Buy
+10
New +$4.91K ﹤0.01% 6331
2021
Q1 		– Sell
-56
Closed -$24K – 7150
2020
Q4 		$24K Buy
56
+16
+40% +$6.38K ﹤0.01% 5811
2020
Q3 		$14K Buy
+40
New +$11.3K ﹤0.01% 5830

Other funds holding KZIA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Wells Fargo's KZIA Position: Q2 2025 in Review

Wells Fargo sold out of Kazia Therapeutics (KZIA) in Q2 2025, closing a stake of 1 share — an estimated $3 sold.

Wells Fargo first reported a position in KZIA in Q3 2020 and held it in 12 quarters. The position peaked at $24K in Q4 2020. 10 funds tracked by Wall St. Rank hold KZIA as of Q2 2025.

  • Wells Fargo reported no remaining Kazia Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 1 Kazia Therapeutics share in Q2 2025, an estimated $3.
  • Wells Fargo first reported a position in Kazia Therapeutics in Q3 2020 and held it in 12 quarters.
  • Wells Fargo's Kazia Therapeutics position peaked at $24K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.